HZHansong Zuo

Hansong Zuo

*This is an algorithmically generated author record based on publicly available information.

Hansong Zuo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Magnetic Nanoparticle Transducers for Magnetogenetics: Materials Design, Biointerfaces, and Transduction Mechanisms

    by Hanlei Wang, Hansong Zuo, Rui He, Kai Wu

    Over the years, magnetic nanoparticles (MNPs) have evolved from passive imaging and delivery agents into active transducers that convert externally applied magnetic fields into localized biological stimuli. This transition has created opportunities for magnetogenetics, in which MNPs serve as remotely controlled biointerfaces for regulating cellular activity, tissue function, and therapeutic responses. In this review, we discuss MNP transducers for magnetogenetics from the perspective of materials design, biointerface engineering, and transduction mechanisms. We start with magnetothermal transduction, where nanoparticles dissipate heat under alternating magnetic fields (AMFs) to activate thermosensitive ion channels such as TRPV1, enabling wireless neuronal activation, deep brain stimulation (DBS), regenerative signaling, and disease therapy. We then discuss magnetomechanical transduction, where nanoparticles, nano/micro-discs, nanochains, etc., generate forces, torques, oscillations, or matrix deformation to activate mechanosensitive channels, integrin-mediated pathways, stem cell differentiation, immune modulation, and tumor inhibition. Next, we examine magnetoelectric transduction, where magnetostrictive-piezoelectric materials convert magnetic inputs into local electric fields or surface potentials for neural stimulation, DBS, nerve regeneration, and wound healing. Across these modalities, biological outcomes are governed by intrinsic magnetic properties and several other factors, including particle geometry, anisotropy, surface chemistry, protein corona formation, tissue retention, field waveform, and proximity to the biological target. We further comment on key design principles, including mechanism-specific dosimetry, geometry-field co-design, biointerface localization, targeting specificity, clearance, and chronic safety. Finally, we highlight opportunities for purpose-built, programmable, and closed-loop magnetic biointerfaces that integrate material architecture, magnetic-field input, and biological target selection for precise control of cellular and tissue function.

  • Open Access

    A systematic framework for harmonic set selection in multiplexed magnetic particle spectroscopy

    by Hanlei Wang, Vinit Kumar Chugh, Ebrahim Azizi, Hansong Zuo, Rui He, Kai Wu

    Magnetic particle spectroscopy (MPS) has emerged as a powerful biosensing modality due to its high sensitivity, matrix-free detection, and compatibility with point-of-care diagnostics. However, the lack of robust multiplexing capability remains a major bottleneck that limits its broader application in complex bioassays. To address this challenge, spatial and spectral separation strategies have been explored in recent years. While spatial separation approaches enable multiplexing without sacrificing sensitivity, they require physically distinct assay regions and substantially increase assay complexity, cost, and reagent consumption. In contrast, spectral separation offers a more resource-efficient solution by decoding multiple analyte signals from a single MPS measurement, but its performance critically depends on the choice of harmonic components used for decoding. In practical multiplexed MPS bioassays, numerical instability in solving harmonic equations directly translates into analyte misquantification and degrades assay performance. Despite significant progress, there is currently no systematic framework to guide the selection of harmonic sets that maximize spectral separation accuracy across different mixture complexities. Herein, we systematically investigate truncated spectral separation across binary, ternary, and quaternary mixtures of distinct magnetic nanoparticle labels by evaluating a wide range of harmonic component combinations under identical experimental conditions. We demonstrate that the absolute determinant of the truncated reference matrix serves as a robust and effective criterion for identifying harmonic sets that yield the lowest decoding error under the evaluated experimental conditions. The proposed harmonic selection framework is demonstrated to be effective across multiple decoding strategies and provides practical design guidance for robust and scalable multiplexed MPS bioassays.


  • Open Access

    Data-driven and physics-informed estimation of magnetic nanoparticle properties via stochastic Langevin model

    by Ebrahim Azizi, Hanlei Wang, Hansong Zuo, Vinit Chugh, Rui He, Kai Wu

    The dynamic magnetization of magnetic nanoparticles (MNPs) arises from coupled Néel and Brownian relaxations, which are influenced by intrinsic particle properties such as size, saturation magnetization, magnetic anisotropy, and damping. While experimental AC magnetization measurements can reveal the collective dynamic behavior of MNP ensembles, extracting accurate nanoparticle-specific parameters from such data remains a challenge due to experimental limitations and model oversimplifications. To address this, we apply a stochastic Langevin model that explicitly captures the time-dependent magnetization response of MNPs under alternating magnetic fields by incorporating both thermal fluctuations and stochastic relaxation processes. This model provides a physically grounded framework for simulating magnetization hysteresis under experimental conditions, enabling parameter estimation through direct data fitting. In this work, we fit the stochastic Langevin model to experimentally measured hysteresis loops of different MNPs collected under a 20 mT, 5 kHz AC field. By coupling the model with Bayesian optimization and Gaussian process regression, we identify optimal values of key magnetic parameters: saturation magnetization ( M s ), effective anisotropy ( K a ), and Gilbert damping parameter ( α ). Furthermore, the M s is experimentally measured and employed as a validation parameter. Accordingly, the determination of the α and the K a is based on two complementary criteria: (1) the best agreement between the simulated and experimental AC response magnetization hysteresis loops, quantified by the coefficient of determination ( R 2 ), and (2) the closest correspondence between the estimated and experimentally measured M s values, evaluated using the mean absolute percentage error. Our approach is validated on four commercial MNP products (SHS30, IPG30, SHP25, and SHP15, from Ocean Nanotech, LLC), yielding high-fidelity fits to experimental data and robust estimation of their magnetic properties.

  • Open Access

    Magnetic nanoparticles for cancer theranostics

    by Jaiden Hart, Linh Nguyen T Tran, Tamara Faranaz Ena, Niranjan A Natekar, Bahareh Rezaei, Yipeng Jiao, Hansong Zuo, Hanlei Wang, Vinit Chugh, Ebrahim Azizi, et al.

    Magnetic nanoparticles (MNPs) have emerged as a powerful tool in cancer theranostics due to their unique size-dependent magnetic properties, surface functionalization capabilities, and responsiveness to external magnetic fields. This review outlines different types of MNPs, including those composed of pure metals, metal oxides, and metallic alloys, and highlights their size-dependent magnetic behavior, such as superparamagnetism and dynamic magnetizations. We also explore the critical role of surface modification strategies in enhancing MNPs’ biocompatibility, colloidal stability, and functional versatility for targeted biomedical applications. The applications of MNPs in cancer therapy are discussed, with a focus on magnetic hyperthermia, drug and gene delivery, and a combination of various therapies. Additionally, we examine their cancer diagnostic roles in imaging techniques such as magnetic resonance imaging (MRI) and magnetic particle imaging (MPI), and emerging magnetic biosensing technologies such as giant magnetoresistance (GMR), magnetic tunnel junction (MTJ), magnetic particle spectroscopy (MPS), and nuclear magnetic resonance (NMR)-based platforms. These advances collectively establish MNPs as key components in the future of personalized cancer diagnosis and treatment.